Ignite Creation Date:
2025-12-24 @ 7:59 PM
Ignite Modification Date:
2025-12-25 @ 5:33 PM
Study NCT ID:
NCT00754104
Status:
WITHDRAWN
Last Update Posted:
2011-01-19
First Post:
2008-09-15
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Study of ABT-869 in Combination With Tarceva in Subjects With Solid Tumors
Sponsor:
Abbott
Organization:
Study Overview
Official Title:
A Phase 1, Open Label Study of ABT-869 in Combination With Tarceva in Subjects With Advanced Non-hematologic Malignancy
Status:
WITHDRAWN
Status Verified Date:
2009-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Study of ABT-869 in Combination with Tarceva in Subjects with Solid Tumors
Detailed Description:
None
Study Oversight
Has Oversight DMC:
Is a FDA Regulated Drug?:
Is a FDA Regulated Device?:
Is an Unapproved Device?:
Is a PPSD?:
Is a US Export?:
Is an FDA AA801 Violation?: